MC
NBIX icon

Machina Capital’s Neurocrine Biosciences NBIX Stock Holding History

Machina Capital’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$390K Sell
2,960
-208
-7% -$27.6K 0.08% 274
2025
Q4 		$449K Buy
+3,168
New +$459K 0.09% 259
2024
Q4 		– Sell
-3,843
Closed -$443K – 339
2024
Q3 		$443K Buy
3,843
+828
+27% +$114K 0.18% 191
2024
Q2 		$415K Sell
3,015
-254
-8% -$34.8K 0.19% 193
2024
Q1 		$451K Sell
3,269
-900
-22% -$123K 0.24% 162
2023
Q4 		$549K Buy
+4,169
New +$480K 0.35% 112
2020
Q1 		– Sell
-4,102
Closed -$441K – 198
2019
Q4 		$441K Buy
4,102
+865
+27% +$90.6K 0.18% 207
2019
Q3 		$292K Buy
+3,237
New +$302K 0.13% 221

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return